MedTrace Logo

A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children

NCT07511920 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-04-06

No results posted yet for this study

Summary

This is a prospective, multicenter, longitudinal observational cohort study aimed at understanding the progression of Duchenne Muscular Dystrophy (DMD). The primary objective is to identify and integrate key biomarkers from multiple sources-including motor function assessments, body composition (muscle and fat distribution), clinical laboratory tests, and cardiopulmonary imaging-to delineate comprehensive disease trajectories. By analyzing how these factors change over time in a large cohort, the study seeks to develop a robust model that can identify patterns of disease progression. The ultimate goal is to generate evidence that may aid in forecasting individual patient outcomes and inform the future development of personalized rehabilitation and therapeutic strategies.

Conditions

  • Muscular Dystrophy, Becker
  • Muscular Dystrophy
  • Muscular Dystrophy (DMD)
  • Muscular Dystrophy, Duchenne

Interventions

OTHER

No interventions are applied; participants are followed for natural history observation only

This is an observational natural history study. No experimental interventions, treatments, or drugs are administered to participants. All data is collected through routine clinical care and follow-up assessments to document the natural progression of Duchenne and Becker Muscular Dystrophy.

Sponsors & Collaborators

  • West China Second University Hospital

    lead OTHER

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-20
Primary Completion
2028-12-30
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07511920 on ClinicalTrials.gov